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Abstract
Migraines are the most common cause of chronic pain. Effective, non-pharmacological
strategies to reduce migraine load are needed. Exercise is an effective strategy, but it is unclear
how exercise timing and temporal preference (chronotype) factors modulate the laudatory
effects of exercise. Purpose: Determine the effects of; 1) time-of-day of exercise, and 2)
exercise synchrony with one’s chronotype, on migraine load. Methods: Participants were 13
sedentary individuals with 8+ migraines/month (age = 30 ± 11 yrs, 167 ± 6 cm, 86 ± 28 kg).
Participants were categorized into morning-/evening-types based on the Morning/Eveningness
Questionnaire and instructed to complete 1 month of self-selected exercise in the morning or
evening (3 sessions per week of 30-min/session at 60-70% of estimated HRmax) in a
randomized cross-over design. Migraine burden was assessed before and after each month of
exercise via questionnaires (Headache Impact Test [HIT-6], Migraine Disability Assessment Test
[MIDAS]). Exercise timing (morning vs evening) as well as synchrony with chronotype (In-Sync
(IS); morning-type exercising in the morning or an evening-type exercising in the evening vs
Out-of-Sync (OOS); morning-type exercising in the evening and evening-type exercising in the
morning). Data was analyzed using a 2 (morning vs evening or IS vs OOS) x 2 (pre, post)
repeated measures ANOVA with significance accepted at p<0.05. Results: MIDAS scores
revealed migraine pain and migraine days were both higher at baseline and post-exercise in the
ME condition (Main Effect Time of Day; p=0.01 and p=0.01, respectively), while HIT-6 scores
tended to decrease following exercise (Main Effect Exercise; p=0.06). In the analysis of exercise
synchrony, we observed a significant interaction effect in HIT-6, migraine days, and MIDAS
scores (p=0.02, p=0.051, p=0.006 respectively). Post-hoc dependent t-tests revealed…,
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suggesting that only IS exercise improved migraine outcomes. Conclusion: Our data suggests
that exercise timing has limited impact, but prescribing exercise in-sync with chronotype in
people with chronic migraines may be an accessible, non-pharmacological option to decreasing
migraine load.
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Introduction
Chronic pain affects millions of US adults each year, with chronic migraines (CM) being
one of the most common forms (23, 8, 18). Migraine inflicts a large burden on the individuals
afflicted by them, as well as a large financial toll, costing the United States between $560 and
$635 million dollars annually (18). In a recent study conducted by Wong et. al., individuals with
migraines were considerably less productive at work (39.1% productivity loss), which in turn
created significant monetary loss for both the company and the individual ($6,176/year lost)
(45). Migraines, with or without aura, are characterized as a cyclic disorder accompanied by
headache-like symptoms, and in some sufferers, photophobia, phonophobia, and transient
focal neurological symptoms (11). An individual is classified as a chronic migraineur by the
International Headache Society when they experience headaches (migraine-like or tensiontype-like) at least 15 days each month for more than 3 months, and of these 15 days, 8 of them
have migraine-like features (11). Alongside the many negative effects of migraines, migraineurs
are at an increased risk of cardiovascular disease (32). The true mechanism behind migraine
development has yet to be discovered. However, previous work to determine contributing
factors that play a significant role in migraine development established that some vascular
molecules alongside calcitonin gene-related peptide (CGRP) may play a role in migraine
development. CGRP was linked to the trigeminovascular system in 1982 with implications for
migraines (10). CGRP is released by the trigeminovascular system during migraine attacks to act
as a vasodilator and maintain cerebral blood flow (9). In a study published in 2022 by
Mozafarihashjin et. al., vascular endothelial growth factor (VEGF) was shown to be significantly
higher in people with CM when compared to control (28). Continued investigation between the
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relationship of VEGF in people with CM is necessary to determine plausible treatment plans to
decrease migraine load. There are many successful treatments that have been shown to
decrease migraine burden but perhaps the most accessible and cost-effective treatment is
exercise.
Exercise has been shown to be an efficacious non-pharmacological intervention to
reduce migraine load in people with CM. In a randomized clinical trial done by Kroll et. al, three
months of aerobic exercise led to a significant decrease in migraine frequency (21.7%), pain
(20.1%), and duration (22.8%), as quantified by a diagnostic headache diary completed by
people with CM(23). Further research confirms that exercise reduces the number of migraine
days (24). Beyond reducing migraine burden, exercise has the added benefit of successfully
treating comorbidities of migraine such as depression, anxiety, and cardiovascular disease.
(Irby, Sacco). The current medications available for treatment of chronic migraines induce
several central nervous system side-effects such as vertigo, somnolescence, ataxia, and aphasia.
The majority of people with CM reported that they are hesitant to take prescription
medications because of the impact of adverse side effects, with this effect increasing among
more severe chronic migraineurs. This avoidance towards medication is supported by the fact
that 79% of sufferers have expressed interest in trying novel treatment strategies that are with
lower adverse effects (Gallagher). With successful implementation, non-pharmacological
interventions may lead to decreased use and reliance on prescription drugs. In fact, Varkey et.
al. showed that 71% of people with CM decreased the use of medicine to treat their migraines
after six months of exercise (39). While exercise has shown proof of concept efficacy, very little
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research has focused on important mediators of exercise prescription such as timing and
circadian preference.
The human circadian rhythm is a recurring ~24-hour cycle of physiological processes
ranging from behavioral patterns of activity/sleep to metabolic and transcriptional regulation at
the cellular level. These cycles are driven by a transcriptional feedback loop known as the
circadian clock that resides in essentially every cell in the body (29). There are two main
transcription factors that make up our circadian clock; brain and muscle arnt-like 1 (Bmal1) and
circadian locomotor output cycles kaput (Clock). Clock and Bmal1 form a transcriptionally active
heterodimer, which initiates transcription of different clock-controlled genes (CCGs), including
negative regulators of the circadian clock like Per2 (which inhibit BMAL1 expression). Several
physiological and behavioral mechanisms operate in synchrony with an individual’s circadian
rhythm including regulation of body temperature and blood pressure (29). Circadian rhythms
are synchronized to our 24-h days by environmental cues known as “zeitgebers” or “timegivers.” There are three primary zeitgebers including light, which is considered the strongest
input for central circadian pacemaker in the suprachiasmatic nucleus (SCN), as well as food and
exercise, which more strongly dictate peripheral rhythms (43). Recent research indicates that
the mechanistic origin of migraines comes from the hypothalamus (6), the same brain region
that houses the SCN, suggesting a link between the two (16, 48). In support, migraines have
been shown to display circadian rhythmicity, and indicates that attacks peak in the morning and
mid-day (1). Furthermore, weekly, monthly, and sometimes even yearly cycles can occur where
migraines are more common in the Spring and Fall seasons (14). While migraine has been
shown to follow rhythmic occurrence, it may differ based on an individual’s circadian or
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temporal preference, known as their chronotype (36, 37). Chronotypes are separated into three
main groups, morning-types, intermediates, and evening-types and can be determined using
the Morning/Eveningness Questionnaire (MEQ) or the Munich Chronotype Questionnaire
(MCTQ) (30, 31). Research has shown that the temporal distribution of migraines synchronizes
with one’s chronotype, where morning-types or evening-types experiencing more migraines in
the morning/evening respectively (38). When using exercise as a treatment for migraine, it is
necessary to understand the effects that exercise may have on a people with CM’s circadian
rhythm, and how circadian preferences may influence the response to exercise at different
times of day.
The circadian rhythm has previously been shown to modulate the perceptual,
physiological, and biochemical response to exercise performed at different times of the day.
Work by Wahlberg and Astrand where men were exercised at 3:00 AM and 3:00 PM showed
that heart rates during exercise at night were consistently lower than daytime exercise, with
three to five beats per minute difference (44). Additionally, Kim et al., found that many
inflammatory markers such as IL-6 were increased to a greater extent after exercise in the
evening than in the morning (21). The human circadian rhythm modulates many cardiovascular
risk markers such as heart rate variability at rest and after exercise, indicating an influence of
exercise timing on these cardiovascular risk markers (12). Furthermore, a recent systematic
review determined that consistent morning exercise facilitated greater exercise adherence and
weight loss when compared to evening exercise in obese patients (33). The results of these
studies exhibit a difference in physiological response to exercise depending on the time of day.
Additional research also indicates a different time-of-day dependent exercise response
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between individuals with different chronotypes, suggesting exercising in synchrony (IS) with
one’s chronotype maybe be better than out of synchrony (OOS). In a study done by Vitale et al.,
morning-type athletes competing in evening exercise were more likely to develop fatigue,
indicating that exercising OOS with one’s chronotype may be deleterious (40-42). This is further
supported by a study completed by Thomas et al. that showed that circadian phase shifts that
are a result of exercise are dependent on chronotype, not just time-of-day of exercise, with
data suggesting that OOS exercise for morning types may be worse than OOS exercise for
evening types (36). In a similar study, after a morning HIIT session, evening-types presented
higher HRV than morning types, indicating differential responses to exercise when exercising IS
or OOS with their chronotype (3, 4). These findings suggest that there is a differential
physiological response to exercise at different times-of-day which could be further augmented
due to chronotype. However, no studies to date have investigated time-of-day dependent
exercise prescription in the context of chronic migraine. Understanding this relationship will
introduce a novel advance to exercise as a treatment to reduce migraine burden. As such, the
purpose of this study was to determine if morning exercise or evening exercise more potently
reduced migraine load. Additionally, we assessed if performing exercise in synchrony (IS) with
one’s chronotype was more effective than out of synch exercise (OOS).
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Methods
Adults aged 18-55 years who self-identified as chronic migraineurs (8+
migraines/month) but were otherwise healthy were recruited for this study. All participants
were not recreationally active prior to beginning their participation in the study and were
nonsmokers, not pregnant, with no history of cardiac, renal, pulmonary, musculoskeletal, or
metabolic disease. This study was approved by the University of Nevada, Las Vegas Institutional
Review Board (#1607166), and all participants provided written informed consent. This study
was registered as a clinical trial with ClinicalTrials.gov (NCT04553445)

Table 1. Demographic Data

Mean ± SD

Age (yrs)

Height (m)

Body Mass (kg)

BMI (kg/m2)

30.1 ± 11.8

1.67 ± 0.06

86.95 ± 28.86

31.1 ± 9.39

Table 1. Demographic data of the participants included in the present study.

Lab visits –
Participants completed two 1-month exercise interventions in a randomized crossed over
design. Laboratory visits took place at the beginning (pre-) and end (post-) of each exercise
condition. Participants were provided with instructions for the exercise, as well as a Polar H9
ECG heart rate monitor (Polar Electro, Lake Success, NY) to track and log their exercise sessions
throughout the study using the Polar App (a timestamp of each exercise session is provided in
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the app, allowing for adherence to timing to be assessed). At each visit, body composition was
measured and questionnaires to determine chronotype (MEQ) and migraine load (HIT-6 and
MIDAS) were completed. Additionally, a blood sample was collected (~0.6 mL) via finger stick
technique, which was used for the assessment of circadian clock gene expression.
Questionnaires –
During the first visit, participants completed the Current Exercise Training Questionnaire to
determine current physical activity level (this was used to recruit ‘sedentary’ participants). At
the first, and each subsequent visit, participants completed the Morning/Eveningness
Questionnaire (MEQ) to determine their chronotype. The distribution of exercise prescription
was assessed in two separate analyses. Firstly, the effects of the time of day of exercise were
assessed by comparing Pre and Post values from Morning Exercise (ME) and Evening Exercise
(EE). Secondly, the effects of synchrony with chronotype were assessed by separating
participant data into IS and OOS groups based on their chronotype and exercise timing. IS data
was classified as a morning-type exercising in the morning and an evening-type exercising in the
evening, while OOS exercise was classified as morning-types exercising in the evening and
evening types exercising in the morning.
Migraine load was evaluated using the Headache Impact Test (HIT-6) (34, 46) and Migraine
Disability Assessment Test (MIDAS) which are both valid and reliable tools for measuring the
impact of chronic migraines (46, 35). MIDAS scores are reported as a value between 0 and 21
with migraine days and migraine pain intensity being recorded during the questionnaire but
evaluated separately. For both questionnaires, lower scores indicate lower migraine burden.
Exercise –
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Participants completed two months of exercise in a randomized, cross-over design with a twoweek wash-out period in between each month of exercise. During each month, participants
were instructed to engage in moderate-intensity exercise (60-70% estimated heart rate max, 3 I
x per week, 30-min/session, 12 sessions total). Age predicted heart rate max was determined
by subtracting their age from 220 (CDC). During the month of Morning Exercise (ME),
participants were instructed to complete exercise sessions any time before 9:00 AM. During the
month of Evening Exercise (EE), exercise sessions were completed after 7:00 PM. Participants
were instructed to complete three workouts per week for four weeks, amounting to twelve
total workouts during each month of the study. Time of day of exercise, exercise session

Figure 1. Representation of study design. Questionnaires and blood draws
occurred at each syringe marker.
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duration, exercise intensity (average heart rate), and adherence to the exercise prescription
([number of sessions completed]/12) were determined from the exercise log (recorded in Polar
App). Each variable was compared between ME vs EE, as well as between IS and OOS exercise.
Anthropomorphic data –
Body composition data were collected during each visit. Height was measured using a
stadiometer. Total body weight and body fat percentage were measured using bioelectrical
impedance (SECA, Chino, CA).
RNA Isolation –
During each visit, capillary blood was drawn using the sterile finger stick technique into an EDTA
coated capillary tube and immediately stored on ice. Blood was mixed 1:5 with Erythrocyte lysis
buffer (Qiagen, Hilden, Germany), incubated for 15 minutes on ice, and centrifuged to isolate
leukocytes for downstream analysis of gene expression. Leukocyte pellets were homogenized
with trizol (Life Technologies, Carlsbad, CA) and RNA was isolated using commercially available
RNA isolation kits (Qiagen, Hilden, Germany and Zymo, Irvine, CA) following manufacturers’
instructions. RNA was stored at -80ᵒC until use for RT-PCR.
RT-PCR –
RNA quantity and quality was assessed via NanoDrop (ThermoFisher, Waltham, MA), and 1000
ng of RNA was reverse transcribed into cDNA using iScript cDNA synthesis kits (BioRad,
Hercules, CA). cDNA was diluted to 5 ng/uL in DEPC water. Gene expression was quantified
using forward and reverse primers custom designed for BMAL1, PER2, VEGF, and ACTB (serving
as a normalizer). Primers were designed using iDTDNA’s PrimerQuest design tool (Integrated
DNA Technologies, Coralville, Iowa), checked for stem-loop and/or primer dimers via deltaG
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(∆G > 0), and for non-specific amplification via BLAST (minimal genes that have 100% Query
Cover). Primer efficiency validation. Gene expression was measured in duplicate reactions of 25
ng cDNA using conventional SYBR green methodology via RT-PCR through 40 cycles, and
calculated using 2-ddCt, reported as fold change from the average of all participants baseline
values at the beginning of each month of exercise.
Statistical analysis –
Values are reported as mean ± SEM unless otherwise specified. When comparing the average
PRE- to POST- change in outcomes between ME and EE, or IS and OOS, we conducted a paired
samples t-test. To assess the effects of the time-of-day of exercise (ME vs EE) and synchrony
with chronotype (IS vs OOS) on the ability to reduce migraine load, we performed two, 2 x 2
within-subjects repeated-measures ANOVA. Differences in migraine load across the months of
ME and EE were assessed with the ANOVA model with fixed factors in terms of exercise (prevs. post-), and time-of-day (ME vs. EE), as well as an interaction. The same analysis was
completed when assessing the difference in migraine load across the months of IS and OOS
exercise with synchrony and exercise set as fixed factors. If an interaction effect was significant,
we performed a paired samples t-test to determine where the significant differences occurred,
with significance accepted at p < 0.05. Analyses were conducted using SPSS version 28 (IBM,
New York, NY) and Microsoft Excel (Microsoft, Seattle, WA). In all cases, p < 0.05 was
considered statistically significant.
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Results
Thirteen participants were recruited for this study. Two participants did not have sufficient RNA
isolated from their blood to complete PCR, but their data was included in anthropometric and
questionnaire data. ME vs. EE outcomes included data from all thirteen participants except for
the gene expression data. Two participants’ data were excluded from IS vs. OOS statistical
analysis because their MEQs indicated that they were intermediate chronotypes, giving their
data no IS or OOS classification. For IS vs. OOS outcomes, data for ten participants data is
included in this report. Two participants were excluded from gene expression analysis for
synchrony due to insufficient RNA yield from their blood. As such, a total of eight participants
were included.
Exercise
Time-of-Day (Morning Exercise vs Evening Exercise) –
Average adherence was 76% through both the morning and evening months combined with no
difference between morning and evening exercise (ME = 74% ± 5% vs. EE = 78% ± 4%, p=0.35).
The median exercise times, as shown in figure 2 for the month of ME and EE was 08:22 AM and
08:08 PM, respectively (p<0.05). The average exercise duration of exercise bouts was 33.2 ± 1.6
mins during the month of morning exercise and 34.1 ± 4.2 mins during the month of evening
exercise, with no difference observed between time-of-day of exercise (p=0.81). Average
exercise heart rate showed no significant difference across time of day of exercise (ME = 121 ±
2 bpm vs. EE = 126 ± 3 bpm, p=0.09). No significant change in body mass was observed (ME =
0.24 ± 0.45 Kg vs. EE = 0.57 ± 0.43 Kg, p=0.6).
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Adherence (%)

Average Exercise Time

Morning Exercise

*

Evening Exercise

0:00

3:00

6:00

9:00

12:00

15:00

18:00

21:00

0:00

Time of day (hh:mm)

80%
70%
60%
50%
Morning
Evening
Time-of-Day

Figure 2. Representation of average exercise time and adherence for ME and EE.

Synchrony –
We observed significantly higher adherence during the month of IS exercise when compared to
OOS exercise (IS = 79 ± 4% vs. 70 ± 5.5%, p=0.03). Exercise timing during the months of IS and
OOS exercise were distributed evenly with the range of exercised times for IS exercise being
between 06:52 AM and 11:05 PM and OOS exercise being 07:19 AM and 9:16 PM (p=0.92)
(Figure 3). The average exercise duration (IS = 34.8 ± 5 mins vs OOS = 34.2 ± 2.6 mins, p=0.88)
and average exercise heart rate (IS = 125 ± 3 bpm vs. EE = 119 ± 2 bpm, p=0.07) was not
significantly different between IS and OOS exercise, although exercise HR showed a near
significant trend. There were no significant differences in body mass lost between IS and OOS
exercise (IS = 0.54 ± 0.5 Kg vs. OOS = 0.46 ± 0.6 Kg, p=0.92).
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Adherence (%)

Average Exercise Time

OOS Exercise

IS Exercise
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70%
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Figure 3. Distribution of time-of-exercise and adherence for IS and OOS exercise.

Migraine Burden
Time-of-Day –
The results of the two-way repeated measures ANOVA are shown in Figure 4. for MIDAS scores
revealed a non-significant trend towards a main effect for TOD (F(1,12)=3.73, p=0.07, ηp2=0.24)
where MIDAS scores at baseline and after the month of morning exercise were higher during
the month of morning exercise (ME = 20.5 ± 4.03 vs. EE = 15.6 ± 3.3, p=0.07). The ANOVA
results also exhibited no main effect for exercise (pre, post-) (F(1,12)=0.23, p=0.64, ηp2=0.02)
and no interaction effect between exercise and TOD (F(1,12)=2.89, p=0.12, ηp2=0.194). The total
migraine days showed a significant main effect for TOD (F(1,12)=8.98, p=0.01, ηp2=0.43) such
that number of migraine days at both exercises were significantly higher during the month of
ME (ME = 12.5 ± 2 days vs. EE = 10.04 ± 2 days, p=0.01). Migraine days showed no main effect
for exercise (F(1,12)=0.03, p=0.87, ηp2=0.002) and no interaction effect between exercise and
TOD (F(1,12)=1.39, p=0.26, ηp2=0.104). Migraine pain did not exhibit a main effect for TOD
(F(1,12)=2.37, p=0.15, ηp2=0.17), exercise (F(1,12)=4.05, p=0.07, ηp2=0.25), and no interaction

13

effect of exercise and TOD (F(1,12)=0.059, p=0.81, ηp2=0.005). HIT-6 scores had no main effect
for TOD (F(1,12)=1.04, p=0.33, ηp2=0.08) but there was a near-significant main effect for
exercise (F(1,12)=3.42, p=0.09, ηp2=0.28). There was no interaction effect between the two
(F(1,12)=0.56, p=0.47, ηp2=0.05).

Migraine Days - TOD

MIDAS - TOD

*

18

30

16
14

# of Migraine Days

average MIDAS score

25
20
15
10

12
10

5

8
6
4
2

0
Morning

0

Evening

Morning

Time-of-Day

70

HIT-6 scores

7

68

Migraine Pain

6

Average Migraine Pain

Average HIT-6 scores

Evening
Time-of-Day

66
64
62
60
58

5
4
3
2
1

56
54

0
Morning

Evening

Morning

Time-of-Day

Evening
Time-of-Day

Figure 4. Changes in migraine load between ME and EE from pre- to post-.
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Synchrony –
The results of the two-way repeated measures ANOVA are shown in figure 5. MIDAS scores
during IS and OOS exercise revealed that there was no main effect of synchrony (F(1,10) =.002,
p=0.96, ηp2<0.001) or time (F(1,10) =1.85, p = 0.20, ηp2=0.16). There was a significant
interaction effect between time and synchrony for MIDAS scores (F(1,10)=14.6, p = 0.003,
ηp2=0.59). Post-hoc tests showed that participant’s MIDAS scores improved after IS exercise
compared to OOS exercise (t(10)=3.32, p=0.004, Cohen’s d=1.001). HIT-6 scores showed a trend
towards a main effect of exercise (F(1,10) =3.84, p=0.078, ηp2=0.58) but not for synchrony
(F(1,10) =0.06, p=0.82, ηp2=0.006). HIT-6 scores did show a significant synchrony 𝗑 time
interaction effect (F(1,10) = 8.22, p =0.02, ηp2=0.45) where HIT-6 scores improved significantly
after IS exercise compared to OOS exercise (t(10)=2.82, p=0.009, Cohen’s d=0.85). The number
of days that the participants had migraines showed no significant main effect for synchrony
(F(1,10) =.51, p=0.49, ηp2=0.049) or exercise (F(1,10) =2.3, p = 0.16, ηp2=0.19) but there was a
significant interaction effect between time and synchrony (F(1,10) =5.76, p=0.037, ηp2=0.37)
such that number of migraine days decreased after IS exercise but increased after OOS exercise
(t(10)=2.83, p=0.009, Cohen’s d=0.85). Migraine pain showed no significant main effects for
synchrony (F(1,10) =1.73, p=0.22, ηp2=0.15) but there was a near significant main effect of
exercise (F(1,10) =4.93, p = 0.051, ηp2=0.33) and no interaction effect as well (F(1,10) =1.47,
p=0.25, ηp2=0.13).
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6
5.5
5
4.5
4
3.5
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3

IS

IS

OOS

OOS

Synchrony

Synchrony

Figure 5. Changes in migraine load between IS and OOS exercise from pre- to post-.

Gene expression
Time-of-day –
Two-way repeated measures ANOVA results indicated that BMAL1 had no significant main
effect of TOD or exercise and no significant interaction effect as well. Analysis of PER2 showed
no main effect of TOD (F(1,10)=0.102, p=0.76, ηp2=0.01) but there was a significant main effect
of exercise (F(1,10)=8.60, p=0.02, ηp2=0.46) where PER2 expression was significantly decreased
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after the month of exercise (pre- = 1.00 ± 0.11 vs. post- = 0.71 ± 0.09, p=0.02), independent of
TOD. PER2 analysis showed no interaction effect between exercise and TOD (F(1,10)=0.21,
p=0.66, ηp2=0.02). VEGF gene expression data mimicked PER2 results where there was not main
effect of TOD (F(1,10)=1.49, p=0.25, ηp2=0.13) and the interaction between exercise and TOD
(F(1,10)=2.49, p=0.15, ηp2=0.19). VEGF did show a significant main effect for exercise
(F(1,10)=7.43, p=0.02, ηp2=0.43) with VEGF decreasing after the month of ME and EE (pre- =
1.00 ± 0.13 vs. post- = 0.82 ± 0.11, p=0.02). These results are exhibited in figure 6.
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Figure 6. Gene expression levels represented as a fold change from baseline for PER2, BMAL1,
and VEGF across ME and EE.

Synchrony –
After analysis of PCR data when looking at synchrony, BMAL1 did not exhibit a main effect of
synchrony (F(1,9) = 0.32, p=0.58, ηp2=0.03) or exercise (F(1,9) = 1.22, p=0.29, ηp2=0.12), or
interaction effect between the two (F(1,9)=0.02, p=0.91, ηp2=0.002). PER2 analysis did show a
significant main effect of synchrony (F(1,8)=5.35, p=0.05, ηp2=0.401) and exercise (F=(1,8)=8.48,
p=0.02, ηp2=0.52) but no interaction effect between exercise and synchrony (F=(1,8)=1.02,
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p=0.34, ηp2=0.11). VEGF expression had no main effect of synchrony (F(1,8)=1.76, p=0.22,
ηp2=0.18) but there was a significant main effect exercise (F(1,8)=6.93, p=0.03, ηp2=0.46). There
was no interaction effect between the two for VEGF (F(1,8)=0.14, p=0.72, ηp2=0.02). All results
are shown in figure 7.
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Figure 7. Gene expression levels represented as a fold change from baseline for PER2, BMAL1,
and VEGF across IS and OOS exercise.
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Discussion
This is the first study to investigate the circadian regulation of exercise induced benefits
in people with CM. As far as we know, this is also the first study to show that synchrony with
one’s chronotype is also an important variable to account for in people with CM using exercise
to reduce migraine burden. In a recent systematic review conducted by Vitale et al. in 2017,
they found only ten published articles examining the effect of chronotype on exercise
performance and perceived exertion. None of the papers reported in this review had
participants exercise over a longer period than one day (42). In the current study, we found that
migraine outcomes were improved after the month of IS exercise compared to the month of
OOS exercise. In particular, MIDAS scores, HIT-6 scores, and migraine days were improved but
IS exercise improved HIT-6 scores more than OOS exercise.
Throughout both months of exercise, there was no significant body composition
changes, including decreases in body fat percentage or changes in lean mass. Although
participants were instructed to complete at least three 30-minute exercise sessions each week,
we only had moderate adherence (~75%, not different between conditions). This constitutes a
relatively mild exercise intervention that falls below generally recommended exercise
prescriptions to see health benefits (ACSM), which could explain why no changes in body
composition were observed. We also analyzed the average heart rate and the average minutes
per exercise session through the bouts of exercise as a measure of exercise intensity and found
no relationship between exercise intensity and migraine burden changes (data not shown).
From this information, we can determine that any improvements to migraine load observed in
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the current study are independent of any body composition changes or differences in the
exercise prescription.
Time-of-Day In the current study, we found that migraine days at baseline and after the month of ME
were increased when compared to EE. The difference in migraine days across ME and EE
months is supported by Alstadhuag et al., where they had patients record their migraines over a
twelve-month period and showed that migraines peak in the morning and mid-day (1).
Although we did not track when migraine attacks occurred, our data does indicate increased
migraine load at baseline and after the month of ME when compared to EE. We did not observe
a TOD-dependent effect of exercise on improving MIDAS scores, HIT-6 scores, and migraine
pain. A systematic review completed by Amin et al., found that in people with CM, regular
exercise has been shown to have positive therapeutic outcomes without causing side effects
(2). Their findings support our data where, although statistical significance was not reached,
HIT-6 scores tended to improve after exercise. This improvement in HIT-6 scores is not
influenced by the TOD at which exercise was performed, suggesting that the improvement can
be attributed to exercise alone. Varkey et al. designed an aerobic exercise program for
untrained chronic migraineurs that was able to increase exercise capacity without making their
migraines worse. In many cases, the exercise program actually reduced migraine frequency,
intensity, and improved quality of life (39).
We also examined gene expression in the blood after each month of EE and ME. We
found that expression of PER2, one of the CCGs, was altered in response to exercise where we
observed a drop in PER2 expression after one month of exercise (independent of time of day).
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In patients with migraines, a mutation in the circadian gene casein kinase I delta (CKIdelta)
causing decreased activity has been identified which may be present among people with CM
(5). This decrease in CKI-delta leads to decreased phosphorylation of Per2 (22) as well as a shift
in sleep phase (5), which supports our findings where PER2 was decreased after exercise. In
contrast to these findings, Ezagouri et al. conducted a study where mice completed exercise in
the morning and in the evening and they found that PER2 expression was induced after exercise
at both time points in skeletal muscle (13). However, these changes were in response to a
single exercise bout, not an exercise intervention.
Gene expression analysis revealed a decrease in VEGF expression in response to exercise
independent of TOD of exercise. VEGF is one of many regulators of physiological angiogenesis
and plasma VEGF is increased in response to exercise in trained and untrained individuals.
Alternatively, VEGF has been shown to play a role in the development of migraines.
Mozafarihashjin et al. measured peripheral biomarkers in the serum of people with CM and
found that VEGF levels were significantly higher in chronic migraine patients when compared to
control patients (28). Furthermore, Michalik el al. reported significant decreases in VEGF levels
in the interictal period (the time between migraine attacks) compared to control (27). These
findings indicate that a reduction in VEGF expression may indicate exercise-induced benefits in
our population. While it may be tempting to speculate that the decrease in VEGF expression
was the mechanism behind the improvement in migraine load, further investigation into the
relationship between exercise timing and VEGF expression in people with CM is necessary for
better understanding of their relationship.
Synchrony –
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After analyzing the effect of TOD on exercise, we sought to examine the relationship between
exercising in-sync or out-of-sync with ones chronotype on exercise adherence, migraine
burden, and gene expression. Our data shows that adherence to IS exercise was significantly
higher than OOS exercise. To our knowledge, this is the first study to evaluate adherence to an
exercise program in this way and represents a clinically impactful tool to improve exercise
prescription. These findings suggest that people with CM are more likely to comply with an
exercise prescription if the exercise is prescribed IS with that individuals chronotype. Previous
studies have shown that people who adhere to exercise are able to manage their migraines in a
more capable and confident manner (26, 15). Exercise induced improvements in migraine load
subjectively while also decreasing gene expression of vascular genes (VEGF) that are involved in
migraine development.
In the current study, we also found that IS exercise improves migraine burden outcomes
when compared to exercising OOS. MIDAS scores improved after the month of exercise, but
scores slightly increased after OOS exercise, with the same pattern being observed in HIT-6
scores. Additionally, the number of migraine days experienced during the month of IS exercise
decreased and OOS exercise caused a minor increase. To our knowledge there are no other
research studies investigating the effects of exercising IS or OOS following chronic exercise in
healthy individuals or people with CM. Data from research studies where individuals completed
acute bouts of exercise in the morning and the evening showed that although there was a
significant effect of time (ME vs. EE) and a significant effect of chronotype on exercise recovery,
there was no interaction between the two variables (41, 42). Sugawara et al. examined the
effect of chronotype on post-exercise vagal reactivation and found that evening-types’ recovery
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following exercise performed at 7:00 AM was worse than morning-types’ recovery at the same
time (40). These findings align with our hypothesis that exercising IS with one’s chronotype will
reduce migraine burden when compared to exercising OOS. The results from the present work
indicate that when using exercise as an intervention to reduce migraine load in people with CM,
it is necessary and important to determine the patient’s chronotype and prescribe exercise insynch with their chronotype to elicit any improvements.
Gene expression analysis between IS and OOS exercise showed that Per2 expression
was decreased at baseline and after the month of IS exercise when compared to OOS exercise.
PER2 expression was decreased after exercise, independent of synchrony. There may be several
explanations for these findings. One possible explanation may be that OOS exercise caused a
shift in participant’s circadian rhythms because they are exercising OOS of their normal or
preferred schedule. Youngstedt et al. has previously shown that exercise causes circadian phase
shifts and Thomas et al. determined that exercise exacerbates circadian misalignment
depending on the individuals chronotype (47, 36). PER2 is one of many CCGs which would lead
to differential expression dependent on circadian phase shifting. VEGF expression was
decreased after exercise which follows the same trend as the TOD VEGF expression. These
findings support our previous explanation where VEGF is increased among people with CM but
exercise decreased VEGF and migraine load improved. Again, the connection between reduced
migraine load and decreased VEGF expression is one of many possible explanations.
Limitations –
While our study followed a rather rigorous randomized cross-over design, several
limitations exist. First, our participants consisted of 13 chronic migraineurs that were self-
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diagnosed (via pre-established cut off criteria for the number of migraine days experienced per
month). We may have been able to observe stronger changes if we had followed stricter
inclusion criteria where participants had to have a diagnosis from a doctor or were referred
from a neurologist. Secondly, while our exercise prescription was designed to be viable to
complete alongside work, school, and other responsibilities among our participants, adherence
was not perfect. Knowing this, we completed an intent-to-treat analysis rather than excluding
participants’ data who did not complete the exercise protocol. Our findings still indicate
improvements in migraine load, even if adherence was not 100%. Also, while we did control for
the TOD of exercise (confirmed by time-stamped exercise logs), and synchrony with
chronotype, we did not control for other lifestyle factors such as diet and sleep, which have
known impacts on migraine. Our exercise prescription (~90 minutes/week) also falls under
ACSM’s threshold for cardiovascular exercise to lose weight which is 150 minutes or more of
moderate intensity exercise, or 75 minutes of vigorous intensity exercise, per week.
Additionally, some participants had trouble with the Polar HR monitors and were unable to
record HR for a few exercise sessions, leading to a loss of some adherence and intensity data.
Another limitation is that we used two different kits to isolate RNA from leukocytes. We used
kits from Zymo and Qiagen. However, we did determine that our PCR results did not differ
based on the kit that was used. Lastly, we only collected blood samples at one time of day
(which was relatively constant among the entire cohort). This limits our ability to describe the
impact of exercise on circadian clock genes, which could be better observed by collecting
samples over a 24-hour time-course.
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Conclusion
Several papers have identified exercise as an important and valuable
intervention to reduce migraine load (23, 24, 20). Further, in healthy individuals, exercise is
widely known to have differential physiological responses and adaptations dependent on the
time-of-day that it is performed (25). At the time of this study, there is no available literature
investigating the efficacy of exercise as an intervention based on the TOD the exercise is
performed in people with CM. Additionally, no study on people with CM or healthy individuals
subjected to chronic exercise IS or OOS of their chronotype have been performed. Previous
research does state that migraine attacks peak in the morning and mid-day (19, 14), which
aligns with our findings where migraine load was increased in the morning. Furthermore, IS and
OOS exercise was an important variable to consider when assessing the efficacy of the exercise
prescription. In particular, migraine burden was not only shown to improve through the month
of IS exercise, but OOS had a negative effect on migraine burden. Based on these findings,
further research should be conducted to examine the effects of chronotypical synchrony as a
critical mediator of the efficacy and adherence to chronic exercise prescriptions in healthy
populations as well as other chronic conditions.
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GPSA Research Grant, UNLV, Spring 2022
TEACHING EXPERIENCE
Part Time Instructor, UNLV, Summer 2020
• Exercise physiology lab
• Assisted with exercise physiology lecture
Graduate Teaching Assistant, UNLV, Fall 2020 - Present
• Exercise physiology lab
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Undergraduate Teaching Assistant, UNLV, Fall 2018
• Reviewed and edited Psychology 210 course
• Graded exams and assignments throughout the semester
PUBLICATIONS AND PRESENTATIONS
Effect of Exercise in Sync with Circadian Preference on Migraine Load in Migraineurs
ELIAS M. MALEK, JAMES W. NAVALTA, FACSM, GRAHAM R. MCGINNIS
Effect of Exercise in Sync with Circadian Preference on Classification of Response and Nonresponse in Migraineurs
JAMES W. NAVALTA, FACSM, GRAHAM R. MCGINNIS, & ELIAS M. MALEK Accepted Abstract at
Southwest ACSM
Validity of Average Heart Rate and Energy Expenditure in Polar Armband Devices While SelfPaced Biking
WYATT B. FULLMER, BRYSON CARRIER, DAMIAN GIL, KYLE CRUZ, CHARLI AGUILAR, DUSTIN
DAVIS, ELIAS MALEK, NATHANIEL BODELL, JEFF MONTES, JAKE MANNING, MARK DEBELISO,
FACSM, JAMES W. NAVALTA, FACSM, MARCUS M. LAWRENCE
Accepted Abstract at Southwest ACSM
Validity of Average Heart Rate and Energy Expenditure in Polar OH1 and Verity Sense While
Self-Paced Running
DAMIAN GIL, BRYSON CARRIER, WYATT B. FULLMER, KYLE CRUZ, CHARLI AGUILAR, DUSTIN W.
DAVIS, ELIAS MALEK, NATHANIEL BODELL, JEFF MONTES, JAKE MANNING, JAMES W. NAVALTA,
FACSM, MARCUS M. LAWRENCE, MARK DEBELISO, FACSM
Accepted Abstract at Southwest ACSM
Evaluating the Validity of the Salatto-Love and Care of Nature Direct Indication Scale Against
the Love and Care of Nature Scale During Rest and After Self-Paced Hiking
RW. SALATTO, DUSTIN W. DAVIS, ELIAS MALEK, JAMES W. NAVALTA, FACSM, JEFF MONTES,
NATHANIEL BODELL, BYRSON CARRIER, JACOB W. MANNING, & MARK DEBELISO, FACSM
Accepted Abstract at Southwest ACSM
Validity of Average Heart Rate and Energy Expenditure in Polar OH1 and Verity Sense While
Self-Paced Walking
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NATHANIEL BODELL, BRYSON CARRIER, DAMIAN GIL3, WYATT B. FULLMER, KYLE CRUZ, CHARLI
AGUILAR, DUSTIN W. DAVIS, ELIAS MALEK, JEFF MONTES, JACOB MANNING, FACSM, JAMES W.
NAVALTA, FACSM, MARCUS M. LAWRENCE, MARK DEBELISO
Accepted Abstract at Southwest ACSM
Diurnal Regulation Of Exercise-induced Anabolic And Catabolic Signaling In White Adipose
Tissue
Elias Malek, Caitlin Reynolds, Charli Aguilar, MS, Graham McGinnis, PhD
Medicine & Science in Sports and Exercise Poster
Time of Day Dependent Effect on Exercise-induced Autophagy in Striated Mouse Muscle.
Elias Malek, Caitlin Reynolds, Charli Aguilar, MS, Graham McGinnis, PhD
Medicine & Science in Sports and Exercise Poster
UNLV Undergraduate Research Symposium Fall 2019 Presentation/Poster
Diurnal Regulation of Exercise-induced Interleukin-6 Signaling
Charli Aguilar, MS, Elias Malek, Caitlin Reynolds, Graham McGinnis, PhD
Medicine & Science in Sports and Exercise Poster
Acute Beta-Alanine Supplementation and Pain Perception Before and After Hiking
James W. Navalta, FACSM, Graham R. McGinnis, Jacob W. Manning, Robert W. Salatto, Bryson
Carrier, Dustin W. Davis, Jacquelyn V.L. Sertic, Peyton C. Cater, Brenna Barrios, Elias M. Malek,
Caitlyn Reynolds, Mark DeBeliso, FACSM
Medicine & Science in Sports and Exercise Poster
Forewarned: Emotional awareness predicts fibromyalgia pain.
Dietz, A. K., Dannen, S., Malek, E., Huang, Y., Barchard, K. A., Doherty, H., Williams, D., &
Lumley, M. (2019, April).
Poster presented at the Western Psychological Association, Pasadena, CA.
PROFESSIONAL SERVICE
Internship, Total Sports Medicine and Orthopaedic, 2014-2015
Dr. Roddy McGee and Dr. Joseph Yu
• Shadowed Dr. Yu and Dr. McGee
• Did the primary examination for the doctor
• Helped the nurses set up for procedures such as draining of fluids, PRP treatments,
injections, etc...
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PROFESSIONAL AFFILIATIONS
American College of Sports Medicine
Western Psychological Association
International Journal of Exercise Science
LANGUAGES
English: Native Language
Arabic: Fluent
COMPUTER SKILLS
•
•
•
•
•

Microsoft Office
ImageJ
SPSS
Python
NanoDrop software

LAB SKILLS
•
•
•
•
•
•
•
•
•
•
•
•

Western Blotting (extensive experience)
Protein isolation
RNA isolation (extensive experience)
RT-PCR
Animal Handling
Metabolic cart testing
Wearable tech validation
SPSS statistics
Animal tissue harvesting
Scientific writing
Statistics analyzing
Creating and optimizing protocols
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